Hikma Pharmaceuticals PLC
HIK
주식 순위
#25464
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the... Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
주가
$22.61
시가총액
$46.82M
변동 (1일)
0.48%
변동 (1년)
-52.37%
국가
GB
거래 Hikma Pharmaceuticals PLC (HIK)
카테고리
Healthcare
의 시가총액 Hikma Pharmaceuticals PLC(HIK)
시가총액: $46.82M
October 2026 기준으로 Hikma Pharmaceuticals PLC의 시가총액은 $46.82M입니다. 이는 당사 데이터에 따르면 Hikma Pharmaceuticals PLC이 세계에서 25464th번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2011부터 2026까지 Hikma Pharmaceuticals PLC의 시가총액 기록
